U.S. TIC Market for Pharmaceuticals and Biotech Industry

Industry Overview

U.S. TIC Market for Pharmaceuticals and Biotech Industry reached USD 9.5 billion in 2030, currently, in 2023 the market is USD 4.6 billion with a projected CAGR of 4.7% from 2025 to 2030.  

Stricter regulations, increased demands for the safety and quality of healthcare products, and supply chain globalization are all contributing to the enormous growth of the U.S. TIC market for pharmaceuticals and biotech industries. Some of the key developments include the need for specialized certifications for advanced medical equipment, the increasing use of outsourced TIC services for transparency, and the use of automation and artificial intelligence (AI) to increase efficiency.

U.S. TIC Market for Pharmaceuticals and Biotech Industry Trends/ Growth Drivers:

Predictive analytics and automated report production are two instances of how automation and artificial intelligence (AI) are being used to improve the effectiveness and precision of testing and inspection procedures. The need for TIC services rises as a result of the EU's extensive regulatory framework for pharmaceuticals and medical devices, which demands stringent testing and certification to guarantee product safety and effectiveness. Additionally, because consumers and healthcare professionals are more conscious of the safety and quality of medical products, corporations are investing in independent TIC services to maintain high standards. Specialized certification services are becoming more and more necessary as medical equipment, especially implanted devices and in-vitro diagnostics, become more complicated and creative. The medical devices market has grown significantly because to strict restrictions and the necessity to ensure safety, making it a crucial area within the larger healthcare TIC industry. Because of their rapid acceptance, new biotech and pharmaceutical technologies like customized drugs and advanced diagnostic tools have a significant impact.

U.S. TIC Market for Pharmaceuticals and Biotech Industry Report Coverage

U.S. TIC Market for Pharmaceuticals and Biotech Industry Challenges:

The United States has a heterogeneous environment with unique local review, reimbursement, and regulatory processes in each member state, despite its aim of unification. Drugs and diagnostic combinations find it more difficult to consistently reach the market as a result. Because there is a greater requirement for data protection and strong cyber-security measures, the increasing reliance on big data and digital technology for testing and inspection poses new compliance issues.

U.S. TIC Market for Pharmaceuticals and Biotech Industry Opportunities:

The major opportunities in the U.S. TIC (Testing, Inspection, and Certification) industry for biotech and pharmaceuticals are strict regulatory compliance, patient safety requirements, and the trend toward outsourcing testing services. Among the specific growth areas are extractable and leachable research, environmental and microbiological testing, material sciences for drug delivery systems, and clinical trial support. Companies might also be able to provide services in the fields of biologics analysis, pharmaceutical procedure development, and sterile compounding testing. 

U.S. TIC Market for Pharmaceuticals and Biotech Industry Segmentation

VynZ Research provides an analysis of the key trends in each segment of U.S. TIC Market for Pharmaceuticals and Biotech Industry report, along with forecasts at the regional and country levels from 2025-2030. Our report has categorized the market based on sourcing type, service type, and industry vertical.

Insight by Sourcing Type

The U.S. TIC market for the pharmaceutical and biotech industry is divided into two segments based on the kind of sourcing that is in-house and outsourced. The in-house dominates as it gives firms control over their technological, skilled and testing and measurement equipment processes through in-house testing, inspection, and certification.

Insight by Service Type

The U.S. TIC market for the pharmaceutical and biotech industry is divided into three segments based on the type of services provided testing, inspection, and certification. Testing segment dominates the TIC market in the pharmaceutical and biotech industry due to diverse standards, rising adoption for improved safety, industrialization, mandatory regulations and a need to provide credibility. 

Insight by Industry Vertical

Extractable and Leachable Studies, Environmental Monitoring, Biopharmaceutical and Biologics Analysis, Sterile Compounding, Pharmaceutical Method Development and Research, pharmaceutical X-ray Diffraction, Excipient Raw Materials and Container Testing, Material Sciences Testing, Disinfection Qualification, Trace Metal Services, and Others are the industry verticals that make up the pharmaceutical and biotech TIC market in the U.S. Among the sterile pharmaceuticals that must be utilized are injectable, compounded, intravenous, and intraocular medications. This prevents pharmacists from using commercially available formulations that would enable them to administer particular medications to patients with particular allergies or dosage needs.

U.S. TIC Market for Pharmaceuticals and Biotech Industry Geographic Overview 

Boston dominates the market in the U.S. TIC Market for Pharmaceuticals and Biotech Industry as it is the home to various biotech firms and anchored by world renowned academic institutions.

U.S. TIC Market for Pharmaceuticals and Biotech Industry Competitive Insight:

The U.S. TIC Market for Pharmaceuticals and Biotech Industry report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                  1.2.1.    By Sourcing Type 
                  1.2.2.    By Service Type 
                  1.2.3.    By Industry Vertical 
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                  1.5.1.  Data Sources
                             1.5.1.1. Primary Research
                             1.5.1.2. Secondary Research
                  1.5.2.  Methodology
                             1.5.2.1. Data Exploration
                             1.5.2.2. Forecast Parameters
                             1.5.2.3. Data Validation
                             1.5.2.4. Assumptions
                  1.5.3.  Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

       3.1.    Industry Dynamics
                 3.1.1.    Market Growth Drivers
                 3.1.2.    Market Restraints
                 3.1.3.    Key Market Trends
                 3.1.4.    Major Opportunities
       3.2.    Industry Ecosystem
                 3.2.1.    Porter’s Five Forces Analysis
                 3.2.2.    Recent Development Analysis
                 3.2.3.    Value Chain Analysis
       3.3.    Competitive Insight
                 3.3.1.    Competitive Position of Industry Players
                 3.3.2.    Market Attractive Analysis
                 3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

       4.1.    Global Market Overview
       4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

       5.1.    By Sourcing Type 
                 5.1.1. In-House
                           5.1.1.1. Market Definition
                           5.1.1.2. Market Estimation and Forecast to 2030
                 5.1.2. Outsourced
                           5.1.2.1. Market Definition
                           5.1.2.2. Market Estimation and Forecast to 2030

       5.2.    By Service Type 
                 5.2.1. Testing
                           5.2.1.1. Market Definition
                           5.2.1.2. Market Estimation and Forecast to 2030
                 5.2.2. Inspection
                           5.2.2.1. Market Definition
                           5.2.2.2. Market Estimation and Forecast to 2030
                 5.2.3. Certification
                           5.2.3.1. Market Definition
                           5.2.3.2. Market Estimation and Forecast to 2030

       5.3.    By Industry Vertical 
                 5.3.1. Extractable and Leachable Studies
                           5.3.1.1. Market Definition
                           5.3.1.2. Market Estimation and Forecast to 2030
                 5.3.2. Environmental Monitoring
                           5.3.2.1. Market Definition
                           5.3.2.2. Market Estimation and Forecast to 2030
                 5.3.3. Biopharmaceutical and Biologics Analysis
                           5.3.3.1. Market Definition
                           5.3.3.2. Market Estimation and Forecast to 2030
                 5.3.4. Sterile Compounding
                           5.3.4.1. Market Definition
                           5.3.4.2. Market Estimation and Forecast to 2030
                 5.3.5. Pharmaceutical Method Development and Research
                           5.3.5.1. Market Definition
                           5.3.5.2. Market Estimation and Forecast to 2030
                 5.3.6. pharmaceutical X-ray Diffraction
                           5.3.6.1. Market Definition
                           5.3.6.2. Market Estimation and Forecast to 2030
                 5.3.7. Excipient Raw Materials and Container Testing
                           5.3.7.1. Market Definition
                           5.3.7.2. Market Estimation and Forecast to 2030
                 5.3.8. Material Sciences Testing
                           5.3.8.1. Market Definition
                           5.3.8.2. Market Estimation and Forecast to 2030
                 5.3.9. Disinfection Qualification
                           5.3.9.1. Market Definition
                           5.3.9.2. Market Estimation and Forecast to 2030
                 5.3.10. Trace Metal Services
                           5.3.10.1. Market Definition
                           5.3.10.2. Market Estimation and Forecast to 2030
                 5.3.11. Others
                           5.3.11.1. Market Definition
                           5.3.11.2. Market Estimation and Forecast to 2030

6.   U.S. Market Estimate and Forecast

      6.1.    By Sourcing Type   
      6.2.    By Service Type   
      6.3.    By Industry Vertical   

7.   Canada Market Estimate and Forecast

      7.1.    By Sourcing Type   
      7.2.    By Service Type   
      7.3.    By Industry Vertical   

8.   Mexico Market Estimate and Forecast

      8.1.    By Sourcing Type   
      8.2.    By Service Type   
      8.3.    By Industry Vertical   

10.  Company Profiles

       10.1.   Intertek Group plc
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   Bureau Veritas
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   UL LLC
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   SGS SA
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   Eurofins Scientific
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   ALS Limited
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   DEKRA SE
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   Applus+
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.1.   TUV SUD
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments

11.    Appendix

         11.1.    Exchange Rates
         11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.